THERATECHNOLOGIES INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.81 CAD | +1.69% |
|
+9.04% | -15.42% |
| May. 09 | Theratechnologies Inc. Announces Frank Holler as Chair of the Board of Directors | CI |
| May. 09 | Transcript : Theratechnologies Inc. - Shareholder/Analyst Call |
Presenter SpeechDawn Svoronos (Executives)Good morning, everyone, and welcome to the Annual Me...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.
Sector
Pharmaceuticals
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.78
CAD
Average target price
6.036
CAD
Spread / Average Target
+239.10%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -15.42% | 59.96M | |
| -1.26% | 89.46B | |
| +2.76% | 40.74B | |
| -9.16% | 33.03B | |
| +55.32% | 24.68B | |
| -16.68% | 15.12B | |
| -9.03% | 12.81B | |
| -12.11% | 11.79B | |
| -43.61% | 11.64B | |
| +7.79% | 8.9B |
- Stock Market
- Equities
- TH Stock
- News Theratechnologies Inc.
- Transcript : Theratechnologies Inc. - Shareholder/Analyst Call
